Human Apolipoprotein A-I
Référence MBS145434-5x1mg
Conditionnement : 5x1mg
Marque : MyBiosource
Apolipoprotein A-I (APOA1) Human Native Protein
For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS145434Description: APOA1 Human isolated from Human HDL is a single, glycosylated, polypeptide chain having a molecular mass of 28.3kDa. APOA1 is purified using delipidation and gel permeation chromatographic technique.Introduction: APOA1 (Apolipoprotein A-1) is a… More details
Product Overview
Online Datasheet in PDFProduct Name
Apolipoprotein A-I (APOA1), Native Protein
Full Product Name
Human Apolipoprotein A-I
Product Gene Name
APOA1 native protein
Product Synonym Names
APOA1 Human; Apolipoprotein A-I Human; Apolipoprotein A-I; Apo-AI; ApoA-I; APOA1; MGC117399
Host
Human HDL
Form/Format
The APOA1 1mg/ml solution contains 10mM Ammonium Bicarbonate at pH7.4.
Sterile filtered colorless solution.
Sterile filtered colorless solution.
Purity/Purification
Greater than 95.0% as determined by SDS-PAGE.
Preparation and Storage
APOA1 although stable at 4 degree C for 1 week, should be stored below -18 degree C. For long term storage it is recommended to add a carrier protein (0.1% HSA or BSA).Please prevent freeze thaw cycles.
Other Notes
Small volumes of APOA1 native protein vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Searchable Terms for APOA1 purchase
MBS145434 is a native protein targeting APOA1. Also known as Human Apolipoprotein A-I. Host: Human HDL.
Additional Details
NCBI/Uniprot data below describe general gene information for APOA1. It may not necessarily be applicable to this product.
NCBI Official Full Name
apolipoprotein A-I preproprotein
NCBI Official Synonym Full Names
apolipoprotein A-I
NCBI Official Symbol
APOA1
UniProt Protein Name
Apolipoprotein A-I
UniProt Synonym Protein Names
Apolipoprotein A1Cleaved into the following 2 chains:Proapolipoprotein A-I; ProapoA-I; Truncated apolipoprotein A-IAlternative name(s):Apolipoprotein A-I(1-242)
Protein Family
Apolipoprotein
UniProt Gene Name
APOA1
UniProt Synonym Gene Names
Apo-AI; ApoA-I; ProapoA-I
UniProt Entry Name
APOA1_HUMAN
NCBI Protein Information
apolipoprotein A-I; apo-AI
NCBI Summary for APOA1
This gene encodes apolipoprotein A-I, which is the major protein component of high density lipoprotein (HDL) in plasma. The protein promotes cholesterol efflux from tissues to the liver for excretion, and it is a cofactor for lecithin cholesterolacyltransferase (LCAT) which is responsible for the formation of most plasma cholesteryl esters. This gene is closely linked with two other apolipoprotein genes on chromosome 11. Defects in this gene are associated with HDL deficiencies, including Tangier disease, and with systemic non-neuropathic amyloidosis. [provided by RefSeq, Jul 2008]
Show more UniProt Comments for APOA1
APOA1: Participates in the reverse transport of cholesterol from tissues to the liver for excretion by promoting cholesterol efflux from tissues and by acting as a cofactor for the lecithin cholesterol acyltransferase (LCAT). As part of the SPAP complex, activates spermatozoa motility. Interacts with APOA1BP and CLU. Component of a sperm activating protein complex (SPAP), consisting of APOA1, an immunoglobulin heavy chain, an immunoglobulin light chain and albumin. Interacts with NDRG1. Major protein of plasma HDL, also found in chylomicrons. Synthesized in the liver and small intestine. The oxidized form at Met-110 and Met-136 is increased in individuals with increased risk for coronary artery disease, such as in carrier of the eNOSa/b genotype and exposure to cigarette smoking. It is also present in increased levels in aortic lesions relative to native ApoA-I and increased levels are seen with increasing severity of disease. Belongs to the apolipoprotein A1/A4/E family.
Protein type: Endoplasmic reticulum; Vesicle; Secreted, signal peptide; Cell development/differentiation; Secreted; Motility/polarity/chemotaxis; Lipid-binding
Chromosomal Location of Human Ortholog: 11q23-q24
Cellular Component: extracellular space; chylomicron; cell surface; endoplasmic reticulum lumen; endocytic vesicle; early endosome; extracellular region; plasma membrane; cytoplasmic vesicle; cytosol; nucleus; vesicle
Molecular Function: identical protein binding; lipase inhibitor activity; beta-amyloid binding; cholesterol binding; phosphatidylcholine binding; high-density lipoprotein binding; protein binding; enzyme binding; phospholipid transporter activity; chemorepellent activity; cholesterol transporter activity; phospholipid binding; apolipoprotein A-I receptor binding; apolipoprotein receptor binding
Biological Process: phototransduction, visible light; negative chemotaxis; negative regulation of lipase activity; axon regeneration in the peripheral nervous system; negative regulation of interleukin-1 beta secretion; sequestering of lipid; regulation of cholesterol absorption; transforming growth factor beta receptor signaling pathway; positive regulation of stress fiber formation; response to drug; platelet activation; cholesterol metabolic process; organ regeneration; regulation of Cdc42 protein signal transduction; adrenal gland development; positive regulation of hydrolase activity; positive regulation of Rho protein signal transduction; lipoprotein metabolic process; positive regulation of transferase activity; vitamin transport; cholesterol biosynthetic process; negative regulation of cytokine secretion during immune response; cholesterol homeostasis; response to estrogen stimulus; lipoprotein biosynthetic process; peptidyl-methionine modification; phosphatidylcholine biosynthetic process; positive regulation of lipoprotein lipase activity; blood vessel endothelial cell migration; cellular lipid metabolic process; platelet degranulation; phospholipid efflux; retinoid metabolic process; transmembrane transport; response to nutrient; phospholipid homeostasis; integrin-mediated signaling pathway; positive regulation of fatty acid biosynthetic process; receptor-mediated endocytosis; regulation of protein amino acid phosphorylation; cholesterol transport; protein stabilization; negative regulation of heterotypic cell-cell adhesion; protein amino acid oxidation; neurite regeneration; cholesterol efflux; glucocorticoid metabolic process; G-protein coupled receptor protein signaling pathway; reverse cholesterol transport; endothelial cell proliferation; negative regulation of inflammatory response; blood coagulation
Disease: Hypoalphalipoproteinemia, Primary; Amyloidosis, Familial Visceral
Show more Protein type: Endoplasmic reticulum; Vesicle; Secreted, signal peptide; Cell development/differentiation; Secreted; Motility/polarity/chemotaxis; Lipid-binding
Chromosomal Location of Human Ortholog: 11q23-q24
Cellular Component: extracellular space; chylomicron; cell surface; endoplasmic reticulum lumen; endocytic vesicle; early endosome; extracellular region; plasma membrane; cytoplasmic vesicle; cytosol; nucleus; vesicle
Molecular Function: identical protein binding; lipase inhibitor activity; beta-amyloid binding; cholesterol binding; phosphatidylcholine binding; high-density lipoprotein binding; protein binding; enzyme binding; phospholipid transporter activity; chemorepellent activity; cholesterol transporter activity; phospholipid binding; apolipoprotein A-I receptor binding; apolipoprotein receptor binding
Biological Process: phototransduction, visible light; negative chemotaxis; negative regulation of lipase activity; axon regeneration in the peripheral nervous system; negative regulation of interleukin-1 beta secretion; sequestering of lipid; regulation of cholesterol absorption; transforming growth factor beta receptor signaling pathway; positive regulation of stress fiber formation; response to drug; platelet activation; cholesterol metabolic process; organ regeneration; regulation of Cdc42 protein signal transduction; adrenal gland development; positive regulation of hydrolase activity; positive regulation of Rho protein signal transduction; lipoprotein metabolic process; positive regulation of transferase activity; vitamin transport; cholesterol biosynthetic process; negative regulation of cytokine secretion during immune response; cholesterol homeostasis; response to estrogen stimulus; lipoprotein biosynthetic process; peptidyl-methionine modification; phosphatidylcholine biosynthetic process; positive regulation of lipoprotein lipase activity; blood vessel endothelial cell migration; cellular lipid metabolic process; platelet degranulation; phospholipid efflux; retinoid metabolic process; transmembrane transport; response to nutrient; phospholipid homeostasis; integrin-mediated signaling pathway; positive regulation of fatty acid biosynthetic process; receptor-mediated endocytosis; regulation of protein amino acid phosphorylation; cholesterol transport; protein stabilization; negative regulation of heterotypic cell-cell adhesion; protein amino acid oxidation; neurite regeneration; cholesterol efflux; glucocorticoid metabolic process; G-protein coupled receptor protein signaling pathway; reverse cholesterol transport; endothelial cell proliferation; negative regulation of inflammatory response; blood coagulation
Disease: Hypoalphalipoproteinemia, Primary; Amyloidosis, Familial Visceral
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
Product Note
Select online data sheet information is drawn from bioinformatics databases, occasionally resulting in ambiguous or non-relevant product information. It is the responsibility of the customer to review, verify, and evaluate the information to make sure it matches their requirements before purchasing the kit. Our ELISA Kit assays are dynamic research tools and sometimes they may be updated and improved. If the format of this assay is important to you then please request the current manual or contact our technical support team with a presales inquiry before placing an order. We will confirm the current details of the assay. We cannot guarantee the sample manual posted online is the most current manual, it is intended to serve as an example only. Please refer to the instructions For Use provided with the assay kit for precise details.
Product PubMed Publications
Products associated with APOA1 native protein
| Reference Product | PubMed Publications |
|---|---|
| APOB native protein | >486 publications with APOA1 and APOB |
| ABCA1 native protein | >130 publications with APOA1 and ABCA1 |
| APOC3 native protein | >72 publications with APOA1 and APOC3 |
| CETP native protein | >60 publications with APOA1 and CETP |
| APOA2 native protein | >42 publications with APOA1 and APOA2 |
| LCAT native protein | >39 publications with APOA1 and LCAT |
| TTR native protein | >8 publications with APOA1 and TTR |
| ALB native protein | >8 publications with APOA1 and ALB |
| FGA native protein | >3 publications with APOA1 and FGA |
Pathways associated with APOA1 native protein
| Products by Pathway | Pathway Diagram |
|---|---|
| ABC-family Proteins Mediated Transport Pathway antibodies | ABC-family Proteins Mediated Transport Pathway Diagram |
| ABCA Transporters In Lipid Homeostasis Pathway antibodies | ABCA Transporters In Lipid Homeostasis Pathway Diagram |
| African Trypanosomiasis Pathway antibodies | African Trypanosomiasis Pathway Diagram |
| African Trypanosomiasis Pathway antibodies | African Trypanosomiasis Pathway Diagram |
| Amyloids Pathway antibodies | Amyloids Pathway Diagram |
| Binding And Uptake Of Ligands By Scavenger Receptors Pathway antibodies | Binding And Uptake Of Ligands By Scavenger Receptors Pathway Diagram |
| Chylomicron-mediated Lipid Transport Pathway antibodies | Chylomicron-mediated Lipid Transport Pathway Diagram |
| Disease Pathway antibodies | Disease Pathway Diagram |
| Diseases Associated With Visual Transduction Pathway antibodies | Diseases Associated With Visual Transduction Pathway Diagram |
| FOXA2 And FOXA3 Transcription Factor Networks Pathway antibodies | FOXA2 And FOXA3 Transcription Factor Networks Pathway Diagram |
Diseases associated with APOA1 native protein
| Disease Name | Pubmed Publications |
|---|---|
| Cardiovascular Diseases Antibodies | >444 publications with APOA1 and Cardiovascular Diseases |
| Atherosclerosis Antibodies | >274 publications with APOA1 and Atherosclerosis |
| Dyslipidemias Antibodies | >185 publications with APOA1 and Dyslipidemias |
| Hyperlipidemias Antibodies | >126 publications with APOA1 and Hyperlipidemias |
| Inflammation Antibodies | >108 publications with APOA1 and Inflammation |
| Insulin Resistance Antibodies | >98 publications with APOA1 and Insulin Resistance |
| Hypertension Antibodies | >81 publications with APOA1 and Hypertension |
| Hypercholesterolemia Antibodies | >66 publications with APOA1 and Hypercholesterolemia |
| Hypertriglyceridemia Antibodies | >58 publications with APOA1 and Hypertriglyceridemia |
| Liver Diseases Antibodies | >52 publications with APOA1 and Liver Diseases |
Organs/Tissues associated with APOA1 native protein
| Organ/Tissue Name | Pubmed Publications |
|---|---|
| Blood Antibodies | >794 publications with APOA1 and Blood |
| Liver Antibodies | >183 publications with APOA1 and Liver |
| Heart Antibodies | >159 publications with APOA1 and Heart |
| Muscle Antibodies | >35 publications with APOA1 and Muscle |
| Brain Antibodies | >33 publications with APOA1 and Brain |
| Lung Antibodies | >21 publications with APOA1 and Lung |
| Intestine Antibodies | >16 publications with APOA1 and Intestine |
| Ovary Antibodies | >15 publications with APOA1 and Ovary |
| Pancreas Antibodies | >7 publications with APOA1 and Pancreas |
| Embryonic Tissue Antibodies | >4 publications with APOA1 and Embryonic Tissue |


